These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 16382694)

  • 1. Autoimmune lymphoproliferative syndrome.
    Fleisher TA; Oliveira JB
    Isr Med Assoc J; 2005 Dec; 7(12):758-61. PubMed ID: 16382694
    [No Abstract]   [Full Text] [Related]  

  • 2. A new peak in the ALPS.
    Fischer A; Rieux-Laucat F; Le Deist F
    Nat Med; 1999 Aug; 5(8):876-7. PubMed ID: 10426307
    [No Abstract]   [Full Text] [Related]  

  • 3. The autoimmune lymphoproliferative syndrome: an experiment of nature involving lymphocyte apoptosis.
    Fleisher TA
    Immunol Res; 2008; 40(1):87-92. PubMed ID: 18193364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA B44 is associated with decreased severity of autoimmune lymphoproliferative syndrome in patients with CD95 defects (ALPS type Ia).
    Vacek MM; Schäffer AA; Davis J; Fischer RE; Dale JK; Adams S; Straus SE; Puck JM
    Clin Immunol; 2006 Jan; 118(1):59-65. PubMed ID: 16257267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The autoimmune lymphoproliferative syndrome. A disorder of human lymphocyte apoptosis.
    Fleisher TA; Puck JM; Strober W; Dale JK; Lenardo MJ; Siegel RM; Straus SE; Bleesing JJ
    Clin Rev Allergy Immunol; 2001 Feb; 20(1):109-20. PubMed ID: 11269222
    [No Abstract]   [Full Text] [Related]  

  • 6. ALPS: an autoimmune human lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis.
    Puck JM; Sneller MC
    Semin Immunol; 1997 Feb; 9(1):77-84. PubMed ID: 9106310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoimmune lymphoproliferative syndromes: genetic defects of apoptosis pathways.
    Rieux-Laucat F; Le Deist F; Fischer A
    Cell Death Differ; 2003 Jan; 10(1):124-33. PubMed ID: 12655301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The multifaceted role of Fas signaling in immune cell homeostasis and autoimmunity.
    Siegel RM; Chan FK; Chun HJ; Lenardo MJ
    Nat Immunol; 2000 Dec; 1(6):469-74. PubMed ID: 11101867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sorting out the causes of ALPS.
    Bleesing JJ
    J Pediatr; 2005 Nov; 147(5):571-4. PubMed ID: 16291343
    [No Abstract]   [Full Text] [Related]  

  • 10. Human autoimmune lymphoproliferative syndrome, a defect in the apoptosis-inducing Fas receptor: a lesson from the mouse model.
    Nagata S
    J Hum Genet; 1998; 43(1):2-8. PubMed ID: 9609991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inactivation of the Fas gene by Alu insertion: retrotransposition in an intron causing splicing variation and autoimmune lymphoproliferative syndrome.
    Tighe PJ; Stevens SE; Dempsey S; Le Deist F; Rieux-Laucat F; Edgar JD
    Genes Immun; 2002 Oct; 3 Suppl 1():S66-70. PubMed ID: 12215906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression in transgenic mice of dominant interfering Fas mutations: a model for human autoimmune lymphoproliferative syndrome.
    Choi Y; Ramnath VR; Eaton AS; Chen A; Simon-Stoos KL; Kleiner DE; Erikson J; Puck JM
    Clin Immunol; 1999 Oct; 93(1):34-45. PubMed ID: 10497009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PI3K/AKT/mTOR hypersignaling in autoimmune lymphoproliferative disease engendered by the epistatic interplay of Sle1b and FASlpr.
    Xie C; Patel R; Wu T; Zhu J; Henry T; Bhaskarabhatla M; Samudrala R; Tus K; Gong Y; Zhou H; Wakeland EK; Zhou XJ; Mohan C
    Int Immunol; 2007 Apr; 19(4):509-22. PubMed ID: 17369192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apoptosis and autoimmunity: two sides to the coin.
    Piacentini M
    Cell Death Differ; 1999 Jan; 6(1):1-2. PubMed ID: 10200540
    [No Abstract]   [Full Text] [Related]  

  • 15. Deletion of receptor for advanced glycation end products exacerbates lymphoproliferative syndrome and lupus nephritis in B6-MRL Fas lpr/j mice.
    Goury A; Meghraoui-Kheddar A; Belmokhtar K; Vuiblet V; Ortillon J; Jaisson S; Devy J; Le Naour R; Tabary T; Cohen JH; Schmidt AM; Rieu P; Touré F
    J Immunol; 2015 Apr; 194(8):3612-22. PubMed ID: 25762779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoimmunity and lymphoproliferation: two genes are worse than one.
    Cohen PL
    Mol Interv; 2002 Nov; 2(7):427-30. PubMed ID: 14993405
    [No Abstract]   [Full Text] [Related]  

  • 17. Genetic disorders of programmed cell death in the immune system.
    Bidère N; Su HC; Lenardo MJ
    Annu Rev Immunol; 2006; 24():321-52. PubMed ID: 16551252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoimmune lymphoproliferative syndromes (ALPS): models for the study of peripheral tolerance.
    Fischer A; Rieux-Laucat F; Le Deist F
    Rev Immunogenet; 2000; 2(1):52-60. PubMed ID: 11324693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disorders of apoptosis: mechanisms for autoimmunity in primary immunodeficiency diseases.
    Oliveira JB; Gupta S
    J Clin Immunol; 2008 May; 28 Suppl 1():S20-8. PubMed ID: 18193340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SLAM-associated protein solves a mystery of autoimmunity.
    Sawada S; Takei M; Ishiwata T; Shiraiwa H; Inomata H; Nozaki T
    Ann N Y Acad Sci; 2007 Aug; 1109():19-30. PubMed ID: 17785286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.